ArticleScientific reports2022
Evaluation of a biocoagulant from devilfish invasive species for the removal of contaminants in ceramic industry wastewater.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 6 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the effectiveness of a biocoagulant produced from the devilfish invasive species and its combination with two chemical coagulants (aluminum sulfate and ferric sulfate) to remove turbidity, chemical oxygen demand, and total suspended solids in ceramic industry wastewater using a combined experimental design of Mixture-Process. This design optimized the coagulation process and evaluated the effects and interactions between mixture components and coagulant doses. An analysis of variance was used to analyze the experimental data obtained in the study, and the response surface plots by response type (turbidity, chemical oxygen demand, and total suspended solids) were obtained. Results showed that the coagulation treatment could be technically and economically feasible since efficiencies of turbidity, chemical oxygen demand, and total suspended solids removal of 74, 79, and 94% could be achieved using an optimal coagulant dose of 800 mg/L with a mixture of 35% biocoagulant and 65% ferric sulfate. Analysis of variance results showed that the models are significant, and the lack of fit is not required according to the probability value (p value), which were < 0.0001, and > 0.05, respectively. Hence, the experimental data were fitted to a combined reduced special cubic x linear model. These results support the use of devilfish meal as a biocoagulant, being more feasible in dual systems when mixed with ferric sulfate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.